{"id":"https://openalex.org/W20823605","doi":"https://doi.org/10.2165/00044011-200020050-00004","title":"Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical Practice","display_name":"Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical Practice","publication_year":2000,"publication_date":"2000-11-01","ids":{"openalex":"https://openalex.org/W20823605","doi":"https://doi.org/10.2165/00044011-200020050-00004","mag":"20823605"},"language":"en","primary_location":{"id":"doi:10.2165/00044011-200020050-00004","doi":"https://doi.org/10.2165/00044011-200020050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00044011-200020050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112493164","display_name":"Richard Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]},{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Richard Johnson","raw_affiliation_strings":["Quintiles, 50 Broadway, 1st Floor, Hawthorne, New York, 10532, USA","Quintiles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles, 50 Broadway, 1st Floor, Hawthorne, New York, 10532, USA","institution_ids":["https://openalex.org/I4210108991"]},{"raw_affiliation_string":"Quintiles","institution_ids":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021921548","display_name":"Jo Ellen Schweinle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jo Ellen Schweinle","raw_affiliation_strings":["Glaxo Wellcome, Inc., Research Triangle Park, North Carolina, USA","Glaxo Wellcome, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome, Inc., Research Triangle Park, North Carolina, USA","institution_ids":[]},{"raw_affiliation_string":"Glaxo Wellcome, Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090736616","display_name":"Scott Burroughs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Burroughs","raw_affiliation_strings":["Glaxo Wellcome, Inc., Research Triangle Park, North Carolina, USA","Glaxo Wellcome, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome, Inc., Research Triangle Park, North Carolina, USA","institution_ids":[]},{"raw_affiliation_string":"Glaxo Wellcome, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.8074,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.83499308,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"20","issue":"5","first_page":"327","last_page":"336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zanamivir","display_name":"zanamivir","score":1.0},{"id":"https://openalex.org/keywords/influenza","display_name":"influenza","score":0.8100000023841858},{"id":"https://openalex.org/keywords/neuraminidase-inhibitors","display_name":"neuraminidase inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.8259999752044678},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.41100001335144043},{"id":"https://openalex.org/keywords/symptom-improvement","display_name":"symptom improvement","score":0.5540000200271606},{"id":"https://openalex.org/keywords/drug-delivery-devices","display_name":"drug delivery devices","score":0.4749999940395355},{"id":"https://openalex.org/keywords/patient-perspectives","display_name":"patient perspectives","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C2781442963","wikidata":"https://www.wikidata.org/wiki/Q146075","display_name":"Zanamivir","level":5,"score":0.9767004251480103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9142718315124512},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8063318729400635},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4772586524486542},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.46140992641448975},{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.4344092905521393},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4082910418510437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3949074149131775},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22021371126174927},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1638387143611908},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14969488978385925},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1334385871887207},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.10224682092666626},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0776742696762085}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2165/00044011-200020050-00004","doi":"https://doi.org/10.2165/00044011-200020050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00044011-200020050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1886211768","https://openalex.org/W2010284659","https://openalex.org/W2015446329","https://openalex.org/W2026359119","https://openalex.org/W2066429701","https://openalex.org/W2101366722","https://openalex.org/W2153531642","https://openalex.org/W2209130389","https://openalex.org/W2282890866","https://openalex.org/W2322969362","https://openalex.org/W2334261876","https://openalex.org/W2412735035","https://openalex.org/W2417507925","https://openalex.org/W2464417828","https://openalex.org/W4210868240"],"related_works":["https://openalex.org/W2209130389","https://openalex.org/W2407835091","https://openalex.org/W1482308682","https://openalex.org/W2259308431","https://openalex.org/W2036255405","https://openalex.org/W2160974867","https://openalex.org/W7099758246","https://openalex.org/W2046339130","https://openalex.org/W2026359119","https://openalex.org/W2334261876"],"abstract_inverted_index":null,"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}